A multitude of studies both on self-esteem and myopia control show kids as young as eight can manage contact lenses safely and competently. Insight speaks with eyecare practitioners and academics about treating this younger age group. Read more


A multitude of studies both on self-esteem and myopia control show kids as young as eight can manage contact lenses safely and competently. Insight speaks with eyecare practitioners and academics about treating this younger age group. Read more

Medicinal cannabis is often presented as an alternative treatment for glaucoma. Although there is evidence that cannabis lowers intraocular pressure, its role as a viable glaucoma therapy is limited by a short duration of action, psychotropic effects, and possible tachyphylaxis.

Opening a greenfield practice during a pandemic in Australia’s hardest-hit city has thrown up its challenges, especially when it comes to purchasing big ticket items. But DR JAYSON STONE found a way thanks to the efforts of a major supplier.

The breadth of choice in lens coatings and treatments plays to the patient’s advantage, whether they are motivated by function, fashion – or both. Insight talks shop with lens manufacturers and dispensers about market trends and retail dynamics. Read more

In the space of 23 years AFT Pharmaceuticals has gone from a home-based business to a multinational company. Its eyecare business is also experiencing remarkable growth, and more therapies are in the pipeline, including one for glaucoma.

Staff across Ocula’s independent optometry network grew tired of their intricate appointment booking system. It’s now been streamlined thanks to a new relationship with a health service platform that’s also driving the business’s digital marketing to patients. Read more

On 1 December, the registration standard for optometrists’ CPD will change from a points-based two-year cycle to a time-based annual cycle. Insight examines the challenges this presents, how optometrists are responding and whether COVID-19 has helped or hindered the impending change-over. Read more

Transitions Optical was one of the world’s first lens brands marketed directly to consumers. Insight details its transformation from a company with a niche product aimed at functional and clinical needs, to a lens portfolio that fulfils the protection and fashion requirements of a broader market. Read more

An additional 79,000 Australians are expected to develop glaucoma in the next five years, costing the economy $4.3 billion [1]. Specsavers optometry director DR BENJAMIN ASHBY explains some of the strategic initiatives, including OCT and visual fields, in place to mitigate this problem.

In the last decade, the optometry workforce has become more feminised and younger, while in ophthalmology women are demanding greater representation and recognition. RHIANNON BOWMAN meets the women striding forward.